Aptevo
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.About APVO
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology.
APVO Key Statistics
Stock Snapshot
Aptevo(APVO) stock is priced at $1.35, giving the company a market capitalization of 23.09M. It carries a P/E multiple of -0.01.
On 2025-11-18, Aptevo(APVO) stock moved within a range of $1.35 to $1.43. With shares now at $1.35, the stock is trading 0.0% above its intraday low and -5.6% below the session's peak.
Trading activity shows a volume of 508.26K, compared to an average daily volume of 710.08K.
Over the past 52 weeks, Aptevo(APVO) stock has traded between a high of $298.00 and a low of $1.32.
Over the past 52 weeks, Aptevo(APVO) stock has traded between a high of $298.00 and a low of $1.32.
APVO News
New insider activity at Aptevo Therapeutics ( (APVO) ) has taken place on November 12, 2025. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can...